The Patent Finder

MSN Laboratories Private Limited

Also on record
Records under this name other than the patents MSN Laboratories Private Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to MSN Laboratories Private Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,279,696Processes for the preparation of 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}quinolin-2(1H)-one
Lapsed on the fee record
Ended Mar 22, 2026 · USPTO record
Lapsed on the fee recordEnded Mar 22, 2026USPTO record
US 10,913,762Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof
Lapsed on the fee record
Ended Feb 9, 2025 · USPTO record
Lapsed on the fee recordEnded Feb 9, 2025USPTO record
US 10,633,372Process for the preparation of amorphous (1S)-1,5-anhydro-1-[3-[[5-(4 fluorophenyl)-2-thienyl]-4-methylphenyl]-D-glucitol and its polymorphs thereof
Lapsed on the fee record
Ended Apr 28, 2024 · USPTO record
Lapsed on the fee recordEnded Apr 28, 2024USPTO record
US 10,633,390Process for the preparation of [(1S,2R)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3R,3AS,6AR)hexahydro furo [2,3-B]furan-3-YL ester and its amorphous form
Lapsed on the fee record
Ended Apr 28, 2024 · USPTO record
Lapsed on the fee recordEnded Apr 28, 2024USPTO record
US 10,562,931Process for the preparation of (1S, 4S, 7Z, 10S, 16E, 21R)-7-ethyldene-4,21-bis(1-methyl-ethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3, 6, 9, 19, 22-pentone
Lapsed on the fee record
Ended Feb 18, 2024 · USPTO record
Lapsed on the fee recordEnded Feb 18, 2024USPTO record
US 10,550,107Process for the preparation of N-[4-[(3-chloro-4-fluoro phenyl) amino]-7-[[(3s-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyl amino)-(2E)-2-butenamide (2Z)-2-butenedioate (1:2) and its polymorphs thereof
Lapsed on the fee record
Ended Feb 4, 2024 · USPTO record
Lapsed on the fee recordEnded Feb 4, 2024USPTO record
US 10,544,189Process for the preparation of (2S)-N-((S)-1-((S)-4-methyl-1-((R)-2-methyl oxiran-2-yl)-1-oxopentan-2-ylcarbamoyl)-2-phenylethyl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)-4-methylpentanamide
Lapsed on the fee record
Ended Jan 28, 2024 · USPTO record
Lapsed on the fee recordEnded Jan 28, 2024USPTO record
US 9,102,664Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
Lapsed on the fee record
Ended Aug 11, 2023 · USPTO record
Lapsed on the fee recordEnded Aug 11, 2023USPTO record
US 10,301,302Crystalline forms of N-(2-chloro-6-methy]phenvn-2-[F6-[4-(2-hvdroxvethvl)-L-piperazin-vil-2-methvil-4-pvrimidinvllaminol-5-thiazolecarboxamide and their process thereof
Lapsed on the fee record
Ended May 28, 2023 · USPTO record
Lapsed on the fee recordEnded May 28, 2023USPTO record
US 9,006,448Process for the preparation of benzimidazole derivatives and its salts
Lapsed on the fee record
Ended Apr 14, 2023 · USPTO record
Lapsed on the fee recordEnded Apr 14, 2023USPTO record
10 of 26 patents shown.
Pro members see all 26.
Pro members: see all 26 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited